Global IV Solution Bags Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global IV Solution Bags Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

IV Solution Bags are primarily used for delivering the medications intravenously. A solution administered into a vein through an infusion set that includes a plastic or glass vacuum bottle or bag containing the solution and tubing connecting the bottle to a catheter or a needle in the patient's vein. Factors such as the availability of specialized medical equipment helps the hospitals and health care centers to maintain the market value. IV Solution Bags are used to deliver liquid substances directly into veins. As the IV Solution Bags meet various medical requirements, such as preserving capacity, sterilization, transportation, and handling needs, the global IV Solution Bags market is anticipated to gain more popularity in the upcoming years.

Market Overview:

The latest research study on the global IV Solution Bags market finds that the global IV Solution Bags market reached a value of USD 3268.22 million in 2022. It’s expected that the market will achieve USD 4747.35 million by 2028, exhibiting a CAGR of 6.42% during the forecast period.

Increased use

The number of surgical procedures is increasing across the globe owing to the growing number of healthcare centers in developed as well as emerging economies and advancements in healthcare facilities. Moreover, favourable reimbursement policies in regions such as North America and Europe will encourage patients to undergo expensive treatments. Growing patient base undergoing surgical procedures for treatment of various diseases will serve to be a high impact rendering factor that will drive the IV Solution Bags market growth during the forthcoming years.
Apart from this, increased use of injections for delivering fluids and medicines, among other liquid nutritional substances directly into the bodies of patients with swallowing issues is contributing to the expansion of the global IV Solution Bags market. In addition, the easy availability, ease of use, cost-effectiveness, and varied kinds based price range and materials make IV Solution Bags a popular medical tool, which, in turn, is fuelling the growth of the market for global IV Solution Bags. The growing penetration of the clinical facilities, particularly in emerging economies, is also fuelling the expansion of the global IV bag market.

Stiff competition

With major manufacturers and suppliers in the IV Solution Bags industry competing at globally, the intensity of competition within the IV Solution Bags industry has increased. The vendors adopt strategies like price premiums to stay competitive in the market. Meanwhile, the local vendors in developing nations are providing tough competition to the global players based on product pricing. The fierce competition is not conducive to the sustainable development of the industry. At the same time, small companies or small retailers enter the business consequently as venturing into a IV Solution Bags business does not require immense capital or investment. However, this leads to the proliferation of sub-standard or duplicate products which then hampers the competitive scenario in the market as established IV Solution Bags manufacturers are compelled to lower the price of their products, which ultimately impacts their profit margins and sales volumes. The fierce competition is not conducive to the sustainable development of the industry

Region Overview:

In global comparison, a significant portion of the revenue was generated in North America (39.92% in 2021).

Company Overview:

Baxter is one of the major players operating in the IV Solution Bags market, holding a share of 31.5% in 2022.

Baxter

Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions.

Fresenius Kabi

Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. its products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology.

Segmentation Overview:

Among different product types, Flex Plastic IV Solution Bags segment is anticipated to contribute the largest market share in 2027.

Application Overview:

The market's largest segment by application is the segment Hospital, with a market share of 63.35% in 2021.

Key Companies in the global IV Solution Bags market covered in Chapter 3:

B.Braun
BAUSCH Advanced Technology Group
Wipak
ICU Medical
Otsuka
Technoflex
Pisa
Sippex
Well Pharma
Cisen Pharmaceutical
CR Double-Crane
POLYCINE GmbH
SSY
Fresenius Kabi
Pharmaceutical Solutions Industry
Huaren Pharmaceutical
Baxter

In Chapter 4 and Chapter 14.2, on the basis of types, the IV Solution Bags market from 2018 to 2029 is primarily split into:

Flex Plastic IV Solution Bags
Semi-rigid IV Solution Bags
Glass Bottles

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the IV Solution Bags market from 2018 to 2029 covers:

Hospital
Clinic
Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)